Document is current

Article History

Received: 27 May 2021

Accepted: 13 January 2022

First Online: 5 April 2022

Declarations

:

: Each randomized controlled trial was conducted in accordance with the Declaration of Helsinki and International Council for Harmonisation Good Clinical Practice Guidelines and was approved by the institutional review board and/or independent ethics committee for each study center. All patients provided written informed consent.

: Not applicable.

: SJ Bartlett is on the Board of Directors of PROMIS, is a steering committee member of PROMIS International, is Co-Director of the PROMIS-Canada initiative, and has been a member of the speakers’ bureaus for or received consultancy fees from AbbVie, Eli Lilly, Janssen, Merck, Novartis, Pfizer Inc, Sandoz, and UCB.CO Bingham has received research grants from Bristol-Myers Squibb and has served as a consultant to AbbVie, Bristol-Myers Squibb, Eli Lilly, Gilead, Janssen, Moderna, Pfizer Inc, Regeneron/Sanofi, and Scipher.R van Vollenhoven has received grants and/or research support from AbbVie, Amgen, Bristol-Myers Squibb, GSK, Pfizer Inc, Roche, and UCB and has acted as a consultant for AbbVie, AstraZeneca, Biotest, Bristol-Myers Squibb, Celgene, Crescendo, Eli Lilly, GSK, Janssen, Merck, Novartis, Pfizer Inc, Roche, UCB, and Vertex.C Murray, D Gruben, and DA Gold are employees and stockholders of Pfizer Inc.D Cella is President of , has received consultancy fees or other remuneration from AbbVie, Alexion Pharmaceuticals, Astellas Pharma, Bayer, Bristol-Myers Squibb, Clovis Oncology, Evidera, Exelixis, Horizon Therapeutics, Janssen, Merck/Schering-Plough, National Academy of Sciences, Novartis Pharma K.K. (Japan), Pfizer Inc, PledPharma, and Regeneron, and is on the board of directors for PROMIS Health Organization.